Bilde av Magnussen, Synnøve
Bilde av Magnussen, Synnøve
Associate Professor Department of Medical Biology synnove.magnussen@uit.no +4777644722 Tromsø You can find me here

Synnøve Magnussen


Job description

Associate Professor in Biomedicine in the Tumour Biology Research Group.

My teaching mainly encompasses MBI-1105 - Basal Biochemistry for the Laboratory Medical Science students and MBI-3004 - The Biology of Cancer for the Masterstudents in Biomedicine. I also supervise Bachelor-, Master-, and PhD-students.


  • Kjersti Sellæg, Ruth Schwienbacher, Mathias Kranz, Anna Engan Aamodt, Anna Maria Wirsing, gerd Berge et al.:
    4-nitroquinoline 1-oxide-induced oral epithelial lesions exhibit time- and stage-dependent changes in the tumor immune microenvironment
    Frontiers in Oncology 2024 DOI / ARKIV
  • Susannah von Hofsten, Manuel K Langer, Katja Korelin, Synnøve Norvoll Magnussen, Dominik Ausbacher, Trude Anderssen et al.:
    Amphipathic barbiturates as marine product mimics with cytolytic and immunogenic effects on head and neck squamous cell carcinoma cell lines
    Frontiers in Pharmacology 30. March 2023 DOI / ARKIV
  • Susannah von Hofsten, Marianne Hagensen Paulsen, Synnøve Magnussen, Dominik Ausbacher, Mathias Kranz, Annette Bayer et al.:
    The marine natural product mimic MPM-1 is cytolytic and induces DAMP release from human cancer cell lines
    Scientific Reports 2022 DOI / ARKIV
  • Julia Baumann, Chih-Chieh Tsao, Shalmali Patkar, Sheng-Fu Huang, Simona Francia, Synnøve Norvoll Magnussen et al.:
    Pericyte, but not astrocyte, hypoxia inducible factor-1 (HIF-1) drives hypoxia-induced vascular permeability in vivo
    Fluids and Barriers of the CNS 2022 DOI / ARKIV
  • Synnøve Norvoll Magnussen, Jimita Prashant Toraskar, Elin Synnøve Hadler-Olsen, Tonje S. Steigedal, Gunbjørg Svineng :
    Nephronectin as a matrix effector in cancer
    Cancers 25. February 2021 DOI / ARKIV
  • Anna Maria Wirsing, Inger-Heidi Bjerkli, Sonja Eriksson Steigen, Oddveig G Rikardsen, Synnøve Norvoll Magnussen, Beate Hegge et al.:
    Validation of Selected Head and Neck Cancer Prognostic Markers from the Pathology Atlas in an Oral Tongue Cancer Cohort
    Cancers 2021 DOI / ARKIV
  • Synnøve Norvoll Magnussen, Jimita Prashant Toraskar, Imola Wilhelm, Janos Hasko, Stine Figenschau, Judit Molnar et al.:
    Nephronectin promotes breast cancer brain metastatic colonization via its integrin-binding domains
    Scientific Reports 2020 DOI / ARKIV
  • Jimita Prashant Toraskar, Synnøve Norvoll Magnussen, Lars Hagen, Animesh Sharma, Linh Hoang, Geir Bjørkøy et al.:
    A Novel Truncated Form of Nephronectin Is Present in Small Extracellular Vesicles Isolated from 66cl4 Cells
    Journal of Proteome Research 01. February 2019 DOI / ARKIV / FULLTEKST
  • Jimita Prashant Toraskar, Synnøve Magnussen, Konika Chawla, Gunbjørg Svineng, Tonje S. Steigedal :
    Nephronectin mediates p38 MAPK‐induced cell viability via its integrin binding enhancer motif
    FEBS Open Bio 2018 DOI / ARKIV
  • Tonje S. Steigedal, Jimita Prashant Toraskar, Richard P. Redvers, Marit Valla, Synnøve Magnussen, Anna M. Bofin et al.:
    Nephronectin is Correlated with Poor Prognosis in Breast Cancer and Promotes Metastasis via its Integrin-Binding Motifs
    Neoplasia 2018 DOI / ARKIV / FULLTEKST
  • Synnøve Magnussen, Elin Synnøve Hadler-Olsen, Daniela Elena Costea, Eli Berg, Cristiane de Albuquerque Cavalcanti Jacobsen, Bente Mortensen et al.:
    Cleavage of the urokinase receptor (uPAR) on oral cancer cells: Regulation by transforming growth factor - beta1 (TGF-beta1) and potential effects on migration and invasion
    BMC Cancer 2017 DOI / ARKIV
  • Oddveig G Rikardsen, Synnøve Magnussen, Gunbjørg Svineng, Elin Synnøve Hadler-Olsen, Lars Uhlin-Hansen, Sonja Eriksson Steigen :
    Plectin as a prognostic marker in non-metastatic oral squamous cell carcinoma
    BMC Oral Health 2015 DOI / ARKIV
  • Synnøve Magnussen, Oddveig G Rikardsen, Elin Synnøve Hadler-Olsen, Lars Uhlin-Hansen, Sonja Eriksson Steigen, Gunbjørg Svineng :
    Urokinase Plasminogen Activator Receptor (uPAR) and Plasminogen Activator Inhibitor-1 (PAI-1) are potential predictive biomarkers in early stage Oral Squamous Cell Carcinomas (OSCC)
    PLOS ONE 07. July 2014 DOI / ARKIV
  • Synnøve Magnussen, Elin Synnøve Hadler-Olsen, Nadezhda Latysheva, Emma Pirila, Sonja Eriksson Steigen, Robert Hanes et al.:
    Tumour Microenvironments Induce Expression of Urokinase Plasminogen Activator Receptor (uPAR) and Concomitant Activation of Gelatinolytic Enzymes
    PLOS ONE 2014 DOI / ARKIV
  • Gunbjørg Svineng, Synnøve Magnussen, Elin Synnøve Hadler-Olsen :
    Plasmin and the plasminogen activator system in health and disease
    2012 DOI
  • Hilde Ljones, Elin Synnøve Hadler-Olsen, Synnøve Magnussen, Oddveig G Rikardsen, sonja eriksson Steigen, elisabeth Sundkvist et al.:
    S100A4 Expression in Xenograft Tumors of human carcinoma cell lines is induced by the tumor microenvironment
    American Journal of Pathology 2011 DOI
  • Tonje Nygård Lillevik, May-Britt Five, Elin Synnøve Hadler-Olsen, Synnøve Magnussen :
    Chst4 as a marker of differentiated tumor-associated high endothelial venules in oral squamous cell carcinoma
    2025
  • Kjersti Sellæg, Susannah von Hofsten, Saikat Das Sajib, Karoline Sollid Evensen, Beate Hegge, Margrethe Similä Vasslag et al.:
    Hva gjør en kreftforsker?
    2025
  • Kjersti Sellæg, Tonje Nygård Lillevik, May-Britt Five, Elin Synnøve Hadler-Olsen, Synnøve Magnussen :
    Chst4 as a marker of dedifferentiated tumor-associated high endothelial venules in oral squamous cell carcinoma
    2025
  • Tonje Nygård Lillevik, Jana Kunder, Kjersti Sellæg, Synnøve Norvoll Magnussen :
    The regulation of high endothelial venules in oral squamous cell carcinoma (OSCC)
    2025
  • Synnøve Norvoll Magnussen, Kjersti Sellæg, Susannah Beatrice von Hofsten, Beate Hegge, Tonje Nygård Lillevik, Karoline Sollid Evensen et al.:
    Hva gjør en kreftforsker?
    2024
  • Agnhild Johansen, Kjersti Sellæg, Synnøve Norvoll Magnussen, May Wenche Jøraholmen, Ann Mari Holsæter :
    Docetaxel liposomes – Can curcumin be co-entrapped and improve the in vitro cytotoxicity?
    2023
  • Anne Kristin Mclaren Berge, Kjersti Sellæg, Stine Figenschau, Saikat Das Sajib, Hallvard Lauritz Olsvik, Maria Perander et al.:
    TRIM32 in Head and Neck Cancer
    2023
  • Kjersti Sellæg, Ruth Schwienbacher, Anna Maria Wirsing, Anna Engan Aamodt, Elin Synnøve Hadler-Olsen, Gerd Berge et al.:
    The spatiotemporal immune profile during mouse oral carcinogenesis
    2023
  • Ruth Schwienbacher, Anna Engan Aamodt, Anna Maria Wirsing, Gerd Berge, Elin Synnøve Hadler-Olsen, Synnøve Magnussen :
    The spatiotemporal immune profile during mouse oral carcinogenesis - high-endothelial venules develop during early stages - and accumulate in late-stage disease
    2023
  • Ruth Schwienbacher, Anna Engan Aamodt, Anna Maria Wirsing, Gerd Berge, Elin Synnøve Hadler-Olsen, Synnøve Magnussen :
    The spatiotemporal immune profile during mouse oral carcinogenesis - high-endothelial venules develop during early stages - and accumulate in late-stage disease
    2023
  • Synnøve Magnussen, Gerd Berge, Ruth Schwienbacher, Anna Maria Wirsing, Elin Synnøve Hadler-Olsen :
    The spatiotemporal immune profile during mouse oral carcinogenesis
    Molecular Oncology 2023 DOI
  • Tonje Nygård Lillevik, Stefanie Bobe, Nadine Bauer, Kjersti Sellæg, May-Britt Five, Friedemann Kiefer et al.:
    Foreign antigen uptake by oral mucous glands, draining lymph nodes, and ovaries
    2023
  • Susannah von Hofsten, Marianne Hagensen Paulsen, Manuel K Langer, Synnøve Norvoll Magnussen, Dominik Ausbacher, Annette Bayer et al.:
    A Compound Inspired by Arctic Marine Animals Kills Cancer Cells in vitro and in vivo
    2022
  • Susannah von Hofsten, Synnøve Norvoll Magnussen, Dominik Ausbacher, Marianne Hagensen Paulsen, Annette Bayer, Morten B. Strøm et al.:
    The Marine Natural Product Mimic MHP88 Shows Anticancer Activity and has the Potential to Cause Immunogenic Cell Death
    2020 ARKIV
  • Synnøve Magnussen, Jimita Prashant Toraskar, Imola Wilhelm, Janos Hasko, Stine Figenschau, Judith Molnar et al.:
    Nephronectin promotes breast cancer brain metastatic colonization via its integrin-binding domains
    2018
  • Synnøve Magnussen, Jimita Prashant Toraskar, Imola Wilhelm, Janos Hasko, Stine Figenschau, Judith Molnar et al.:
    Nephronectin (Npnt) promotes breast cancer brain metastasis via its integrin binding domains
    2017
  • Synnøve Magnussen :
    Et viktig puslespill...
    Andøyposten 2017
  • Synnøve Magnussen :
    The metastasis-promoting protein Nephronectin
    2016
  • Synnøve Magnussen, Imola Wilhelm, Janos Hasko, Judith Molnar, Marit Seppola, Elin Synnøve Hadler-Olsen et al.:
    The metastasis-promoting protein Nephronectin
    2016
  • Gunbjørg Svineng, Synnøve Magnussen, Elin Synnøve Hadler-Olsen, Nadezhda Latysheva, Emma Pirila, Sonja Eriksson Steigen et al.:
    Stromal induced expression of uPAR
    2013
  • Chandra Sekhar Ravuri, Synnøve Magnussen, Jan-Olof Winberg, Nils-Erik Huseby, Gunbjørg Svineng :
    The effect of elevated levels of reactive oxygen species on oral squamous carcinoma cell adhesion and invasion
    2007

  • The 50 latest publications is shown on this page. See all publications in Cristin here →


    Research interests

    Magnussen's research focuses on tumour biology, with a particular emphasis on the tumour microenvironment and tumour immunology.

    A key area of interest lies in understanding how tolerance towards food and microbes is developed and maintained, and whether oral cancer exploits these natural processes to facilitate cancer immune escape. While it is widely believed that the intestines play a central role in building tolerance to ingested substances and microbes, Magnussen hypothesizes that the oral cavity also contributes significantly to the development of tolerance.

    Magnussen is actively involved in the multicenter research project, the NORwegian Oral Cancer study (NOROC). This study aims to identify prognostic markers that can be integrated into clinical practice to enhance treatment strategies for oral cancer patients.

    Magnussen's previous research experience includes work on extracellular matrix proteins, proteolytic enzymes, and the mechanisms of cancer invasion and metastasis in breast cancer as well as head and neck cancer.

    Teaching

    Magnussen currently teaches primarily biochemistry at the bachelor's level and cancer biology at the master's level, where she serves as a lecturer, supervisor, and examiner:

    Course leader, lecturer, supervisor, and examiner for MBI-1105 Basic Biochemistry in the Biomedical Laboratory Science program (2023–).
    Lecturer and examiner for MBI-3004 The Biology of Cancer in the Master's program in Biomedicine (2018–).


    Magnussen has been involved in teaching-related activities since 2005, including student laboratories, study groups, seminars, and examination work at the bachelor's, master's, and PhD levels. She has supervised bachelor’s, master’s, and PhD student projects for several years. Magnussen also has experience as a course leader.


    Member of research group



    CV

    2022- Associate Professor in Biomedicine - TBRG, IMB, UiT 

    2018-2024 Research group leader for the Tumour Biology Research Group (TBRG), IMB, UiT

    2022 - Research stay (3 mo) - Max Planck Institute/EIMI, Münster, Germany in Professor Friedemann Kiefers lab. Project: Oral mucous glands as facilitators of cancer immune escape

    2018-2022 Researcher - TBRG, IMB, UiT. Project: High endothelial venules - master regulators of the immune infiltrate in oral cancer

    2015-2016 Research stay (1 yr) - Biological Research Centre in Professor Istvan Krizbai’s lab, Szeged, Hungary. Project: Breast cancer brain metastasis

    2015-2018 Post Doctoral Fellowship - TBRG, IMB, UiT. Project: The metastasis-promoting protein Nephronectin: distribution and mechanisms of action.

    2011 - Research stay (1 mo) - Uppsala University, BMC, Sweden in Professor Staffan Johansson’s lab. Project:  TIRF microscopy of adhering oral cancer cells

    2009-2015 Doctoral Research Fellow (PhD) in Tumour Biology, supervisor Professor Gunbjørg Svineng. Project: Oral Squamous Cell Carcinoma – Role of the Plasmniogen Activation System in Tumour Progression


    MH øst L8.226B


    Click for bigger map